Delay for Eurand's Zenpep

Eurand N.V. (NASDAQ:EURX) said FDA pushed back the PDUFA date for an NDA for Zenpep pancrelipase capsules to treat pancreatic exocrine insufficiency to September from June. Eurand said the agency need...